| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $63.1M | -39.2% |
| SG&A Expense | $21.8M | -15.8% |
| Operating Income | -$73.9M | +43.0% |
| Income Tax | $0 | — |
| Net Income | -$69.8M | +43.5% |
| EPS (Basic) | -$1.44 | +44.2% |
| EPS (Diluted) | -$1.44 | +44.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $49.0M | -56.0% |
| Current Assets | $51.2M | -56.0% |
| Total Assets | $52.4M | -56.2% |
| Current Liabilities | $14.5M | -48.7% |
| Total Liabilities | $38.2M | -22.1% |
| Stockholders' Equity | $14.3M | -79.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$71.9M | +30.8% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $9.5M | — |